SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-017478
Filing Date
2019-04-01
Accepted
2019-04-01 17:00:29
Documents
5
Period of Report
2019-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv517664_8k.htm 8-K 20850
2 EXHIBIT 10.1 tv517664_ex10-1.htm EX-10.1 40317
3 EXHIBIT 99.1 tv517664_ex99-1.htm EX-99.1 11842
4 GRAPHIC image_001.jpg GRAPHIC 3292
5 GRAPHIC image_002.jpg GRAPHIC 2536
  Complete submission text file 0001144204-19-017478.txt   82673
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38045 | Film No.: 19721535
SIC: 2834 Pharmaceutical Preparations